Sedating Effects of Dexmedetomidine Versus Midazolam in Agitated Patients Undergoing Weaning in Icu.
Agitation on Recovery From Sedation
About this trial
This is an interventional health services research trial for Agitation on Recovery From Sedation
Eligibility Criteria
Inclusion Criteria:
- all patients with age <60 irrespective of gendre
Exclusion Criteria:
- Patients who refuse to give consent, severely altered conscious level (GCS < 8/15), traumatic injury causing hypoxemia e.g., severe head / chest / facial trauma or pneumothorax, severe pneumonia, arrhythmia, impaired hearing or blindness, severe hepatic or renal disease, on neuromuscular blocking agents, recent myocardial infarction, use of anti-psychotics, hypersensitivity to any of the drug under study.
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Experimental
Experimental
Dexmedetomidine
Midazolam
Inj.Dexmedetomidine(precidex ) 200mcg/2ml Given to participants in infusion form for 24 hours
Inj.midazolam 5mg/ml given to participants in infusion form for 24 hrs